Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2003
06/11/2003CN1423549A Personal care articles comprising a hydrophilic conditioning agent exhibiting a defined leaching value
06/11/2003CN1422891A Optimized grain formula
06/11/2003CN1422871A Working-resisting low-straight-chain starch dimandioc adipate
06/11/2003CN1422659A Musk slow-controlled release preparation and preparation method thereof
06/11/2003CN1422655A Throat lozenge
06/11/2003CN1422650A Ointment for treating various skin diseases and preparation method thereof
06/11/2003CN1422633A Formula of suning-kechuantie-plaster for treating cough and asthma and production technology thereof
06/11/2003CN1422630A Lamina ointment for quickly treating burn and preparation method thereof
06/11/2003CN1422626A Pseudo-ginseng instant powder and its preparation method
06/11/2003CN1422623A Chinese medicine composite external for treating alopecia areata and its preparation method
06/11/2003CN1422620A Aerosol for treating poisoning by nitrogen oxide and its use and preparation method
06/11/2003CN1422619A Lipid composition of high non-soluble platinum matches and lipid body
06/11/2003CN1422618A 9-nitrocamptothecin solid dispersant and preparation method
06/11/2003CN1422617A Integerrimine liposome gel preparation and preparing method
06/11/2003CN1422613A Liver-tonifying medicine slow-release plaster
06/11/2003CN1422612A Nano-grade medicine controlled-releasing technology and preparation and use for viformicoid preparation
06/11/2003CN1422611A Albendazole lipid and method for preparing said lipid by neutralization method
06/11/2003CN1422609A Microcapsul water-aqua type cosmetic, personal care article and external-use medicine
06/11/2003CN1111067C Preparation of freeze-dried spirulina powder containing diabetes resisting factor
06/11/2003CN1111065C Plaster for curing mastosis
06/11/2003CN1111063C Capsule for treating gonorrhoea and its preparation process
06/11/2003CN1111044C Process for preparing garlic injection
06/10/2003US6577899 Microprocessor controlled ambulatory medical apparatus with hand held communication device
06/10/2003US6576712 Polymer and plasticizing agent are capable of hydrogen or electrostatic bonding to each other and are present in a specific ratio
06/10/2003US6576679 Hydrogel
06/10/2003US6576677 Medicinal compositions with relieved bitterness
06/10/2003US6576666 First fatty acid compound that is a linoleic or linolenic compound and a second fatty acid that is a docosahexaenoic acid compound, an omega-3 or an omega-2 fatty acid or derivative
06/10/2003US6576651 Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones
06/10/2003US6576649 Method for treating pharmaceutical compositions
06/10/2003US6576635 Compositions comprising trimetrexate
06/10/2003US6576625 Targeted vesicular constructs for cytoprotection and treatment of H. pylori infections
06/10/2003US6576619 Orally active A1 adenosine receptor agonists
06/10/2003US6576618 Cholesterol containing cationic liposome having gene encoding insulin like growth factor I
06/10/2003US6576617 Dispersing natamycin particles in perishable food
06/10/2003US6576355 Nanotechnology for electronic and opto-electronic devices
06/10/2003US6576270 Herbal composition and medicament against diabetes mellitus type II manufactured thereof
06/10/2003US6576266 A mixture of di-O-D-galactosyl-di-O-acylglyceride with phytosphingolipids and phospholipids
06/10/2003US6576264 Insoluble drug delivery
06/10/2003US6576263 Crosslinked polymer
06/10/2003US6576262 Methods and apparatus for particle formation
06/10/2003US6576260 Sustained-release form of administration containing tramadol saccharinate
06/10/2003US6576259 Sustained release formulations containing tacrolimus
06/10/2003US6576258 Anhydrous granulation of active substances and dried pharmaceutically acceptable auxiliary substances for the preparation of pellet cores or granules, drug delivery
06/10/2003US6576256 Treatment of patients at elevated cardiovascular risk with a combination of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
06/10/2003US6576255 Capsules for drug delivery
06/10/2003US6576254 Drug delivery, gene therapy
06/10/2003US6576252 Composition providing calming, stress hormone regulating and immune stimulation effect, which comprises component including combination of linoleic and linolenic acids in specified ratio, and component taken from flavonoid group
06/10/2003US6576250 Administering in rectum of mammal dosage form comprising therapeutically effective amount of active ingredient and at least one effervescent penetration enhancer sufficient to increase absorption across mucosa layer of target area
06/10/2003US6576245 Primary package containing aqueous solution for parenteral administration comprising low molecular weight peptide-based thrombin inhibitor or salt,and having specified pH, sealed with rubber stopper or plunger containing bromobutyl rubber
06/10/2003US6576227 Peroxidase-activating oral compositions
06/10/2003US6576224 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
06/10/2003US6576221 Iron-containing nanoparticles with double coating and their use in diagnosis and therapy
06/10/2003US6576220 Non-invasive methods for surgery in the vasculature
06/10/2003US6576155 Ink jet printing; images or security marks for documents
06/10/2003US6575961 Fluid delivery device and associated method
06/10/2003CA2350195C Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate
06/10/2003CA2284754C Centre filled confectionery
06/10/2003CA2284753C Throat soothing compositions
06/10/2003CA2225286C A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof
06/10/2003CA2216277C Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance
06/10/2003CA2200651C Sodium alendronate preparation for local administration
06/10/2003CA2132451C Process for the preparation of sustained release pellets
06/10/2003CA2108039C Lipid vesicle containing water-in-oil emulsions
06/10/2003CA2104096C A method of highlighting intagliations in tablets
06/10/2003CA2098816C Cosmetic or pharmaceutic composition in the form of a rigid gel, particularly for containing inclusions therein
06/10/2003CA2090954C Binder comprising pullulan and saccharide(s)
06/10/2003CA2078999C Halohydrocarbon-free delayed release lacquer solution for pharmaceutical preparation
06/10/2003CA2072047C Pharmaceutical compositions
06/10/2003CA2071757C Implant compositions containing a biologically active protein, peptide or polypeptide
06/10/2003CA2065553C Stabilized factor viii preparations
06/07/2003CA2412838A1 Filtering composition containing a dibenzoylmethane derived filter type and a 2-hydroxybenzophenone aminosubstituted derived filter type
06/06/2003CA2364414A1 Iontophoretic drug delivery device and reservoir and method of making same
06/05/2003WO2003046145A2 Materials and methods for making improved liposome compositions
06/05/2003WO2003045965A2 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same
06/05/2003WO2003045945A1 5-(4-(2-(n-methyl-n-(2-pyridyl)amido)ethoxy)benzyl)thiazolidine-2,4-dione and pharmaceutical compositions comprising the same
06/05/2003WO2003045844A1 Calcium metasilicates and methods for making the same
06/05/2003WO2003045610A2 Nano-dispersed powders and methods for their manufacture
06/05/2003WO2003045545A1 Gel capsules containing active ingredients and use thereof
06/05/2003WO2003045452A1 Medical dressings
06/05/2003WO2003045437A1 Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene
06/05/2003WO2003045435A1 Formulations comprising a cephalosporin compound and their use treating bacterial infections in cats and dogs
06/05/2003WO2003045419A1 Injection solution comprising an lhrh antagonist
06/05/2003WO2003045418A1 Medicinal compositions for nasal absorption
06/05/2003WO2003045411A2 Ginger extract preparation
06/05/2003WO2003045410A1 Pharmaceutical preparation containing micro-encapsulated or nano-encapsulated ginsenosides
06/05/2003WO2003045409A1 A pharmaceutical composition made from chinese traditional medecine and method of producing thereof
06/05/2003WO2003045391A1 Pharmaceutical formulations comprising an immune response modifier
06/05/2003WO2003045383A1 Use of ppar activators for the treatment of pulmonary fibrosis
06/05/2003WO2003045371A1 Pharmaceutical compositions and methods for administering ep2 receptor selective agonists
06/05/2003WO2003045370A1 Pharmaceutical composition for treating obesity
06/05/2003WO2003045366A1 Treatment of wounds and compositions employed
06/05/2003WO2003045358A1 TRANSDERMAL THERAPEUTICAL SYSTEM FOR THE ADMINISTRATION OF 17α ESTRADIOL
06/05/2003WO2003045357A1 Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
06/05/2003WO2003045356A1 Pharmaceutical dosage form with multiple coatings
06/05/2003WO2003045355A1 Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus
06/05/2003WO2003045354A1 Micropherules containing a pleuromutilin derivative
06/05/2003WO2003045353A1 Method for the preparation of pharmaceutical nanosuspensions using supersonic fluid flow
06/05/2003WO2003045352A2 Osmotic delivery device having a two-way valve and dynamically self-adjusting flow channel
06/05/2003WO2003045351A1 Controlled release polymeric compositions of bone growth promoting compounds
06/05/2003WO2003045350A2 Device for incorporating substances which contain a sea sponge as a support
1 ... 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 ... 2991